Search

Your search keyword '"Garcia-Ribas G"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Garcia-Ribas G" Remove constraint Author: "Garcia-Ribas G"
46 results on '"Garcia-Ribas G"'

Search Results

1. Assessing Knowledge and Perceptions of Alzheimer’s Disease Among Employees of a Pharmaceutical Company in Spain: A Comparison Between Caregivers and Non-Caregivers

3. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

4. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

7. New insights into the genetic etiology of Alzheimer's disease and related dementias

8. New insights into the genetic etiology of Alzheimer's disease and related dementias

9. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

10. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

11. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

15. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

16. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE epsilon 4 Non-carriers

17. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ¿4 Non-carriers

18. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

19. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

20. «Apuntes en Neurologia»: una sintesis de la evidencia en trastornos neurologicos comunes paroxisticos y en trastornos neurodegenerativos

25. «Apuntes en Neurologia» (Notes in Neurology): a synthesis of the evidence on common paroxysmal neurological disorders and on neurodegenerative disorders,«Apuntes en Neurologia»: una sintesis de la evidencia en trastornos neurologicos comunes paroxisticos y en trastornos neurodegenerativos

30. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

31. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.

32. Medical help-seeking intentions among patients with early Alzheimer's disease.

33. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes.

34. Burnout among neurologists caring for patients with cognitive disorders in Spain.

35. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men.

36. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease.

37. Retrospective Analysis of EEG in Patients With COVID-19: EEG Recording in Acute and Follow-up Phases.

38. Genomic Characterization of Host Factors Related to SARS-CoV-2 Infection in People with Dementia and Control Populations: The GR@ACE/DEGESCO Study.

39. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.

40. Quantifying Knowledge of Alzheimer's Disease: An Analysis of the Psychometric Properties of the Alzheimer's Disease Knowledge Scale.

41. Validation of a novel and accurate ApoE4 assay for automated chemistry analyzers.

42. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion.

43. [«Apuntes en Neurologia» (Notes in Neurology): a synthesis of the evidence on common paroxysmal neurological disorders and on neurodegenerative disorders].

44. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.

45. [Cognitive impairment as a predictor of functional decline after hospitalization: DECOFIRH Study].

46. Use of topiramate in treatment-resistant bipolar spectrum disorders.

Catalog

Books, media, physical & digital resources